エピソード

  • Fame, Addiction, and What Finally Worked | The Saving Dose Ep. 19
    2026/11/10
    Adams Pritchard went to roughly 17 treatment centers before a 12-step program in Texas in 2015 finally reached him. A Mountain Brook native, University of Alabama graduate, and by most external measures, someone whose life looked intact, he spent years walking out of facilities clean, following the instructions, and relapsing anyway. What he eventually understood was why: treatment programs were separating him from the only solution he had ever known without giving him another one. He came home with a different idea. Impact Recovery Center in Odenville, Alabama opened in 2020. Fourteen clients. Men only. No insurance. Built around the authentic 12-step process combined with individualized clinical work, family programming three days a week, and a core conviction that the mind and the spirit are connected and both have to be treated.Jason Waller became known on MTV’s Laguna Beach and The Hills before Celebrity Rehab with Dr. Drew made the struggle public. What viewers saw as a lifestyle was, by Jason’s own account, a war he had been losing since he was twelve years old, when debilitating OCD was already running his life behind closed doors before he ever picked up a drink or a drug. Between the ages of 18 and 23 he went through 12 programs, from Florida to Hawaii. His disease led him to contemplating and attempting suicide. His turning point came not because he wanted recovery for himself, but because he looked across a therapist’s office and saw his parents aging ten years in two. July 23rd, 2010. He will have seven years again in December. Eight members of his family are now sober.Timestamps00:00 Introduction02:38 Welcome and guest introductions05:06 Adams Pritchard: how the life that looked perfect fell apart at 1509:00 Wanting to get better every time and relapsing anyway13:00 What finally worked: treating the mind, the body, and the spirit together14:21 Jason Waller: OCD at 12, addiction by the time the cameras showed up18:00 12 programs, suicide attempt, and the moment in the therapist’s office20:12 Stigma is a symptom of treatment failure, not personal failure23:00 The turning point that is not what people expect27:11 What families get wrong and what actually helps28:02 Codependency, enabling, and the difference between love and protecting someone from consequences32:41 Boundaries are not the opposite of love35:40 What was underneath: OCD, fear, identity, and the broken internal condition41:17 Dr. John on medication, withdrawal, the psychosocial piece, and what medicine misses in 8 minutes47:50 Rigid structure, flexible dosing, and what boundaries have to do with recovery50:41 The Suboxone debate: short-term bridge versus long-term maintenance53:05 If you don’t use by 21, 90% chance you never struggle with addiction56:29 No consensus in treatment after 75 years of trying59:48 Faith, the 12 steps, and the spiritual component that keeps getting cut1:04:09 John’s heart attack, a heart rate of 10, and what he decided if he lived1:07:48 Impact Recovery Center and what Jason is building now1:09:37 Closing: purpose, the bonus round, and why none of them should still be hereAbout the HostsWilliam Pedranti is a Georgetown Law graduate, co-founder of PENG Life Science Ventures, and COO of iPill Adherence Tech Services. He has taken a company from founding through FDA approval, commercial launch, and exit, and lectures at USC on what venture capital actually evaluates in biomedical investments.Dr. John Hsu MD is a board-certified anesthesiologist with 25 years of pain management experience, founder and CEO of iPill Adherence Tech Services, and a serial FDA regulatory builder.About the GuestsAdams Pritchard is the president of Impact Recovery Center in Odenville, Alabama, a small men-only residential program built around the authentic 12-step process combined with individualized clinical care and a full family program. He went through approximately 17 treatment programs before finding recovery in 2015. Find Impact Recovery Center at impactrecoverycenter.com.Jason Waller is a speaker, recovery advocate, and former cast member of MTV’s Laguna Beach, The Hills, and Celebrity Rehab with Dr. Drew. He has worked with the Change Your Brain Foundation, Cure Addiction Now, and the Yana Project. He and his wife Ashley share the less polished side of recovery, marriage, and parenting through their series Jaws.Website: thesavingdose.comIf you or someone you know is struggling with addiction, the SAMHSA National Helpline is available 24 hours a day, 7 days a week: 1-800-662-4357. It is free, confidential, and available in English and Spanish.#TheSavingDose #AddictionRecovery #OpioidCrisis #MentalHealth #RecoveryStories #SoberLiving #AdamsAndJason #ImpactRecoveryCenter #JasonWaller #FaithAndRecovery #TreatmentWorks #OUD
    続きを読む 一部表示
    1 時間 10 分
  • What Families Get Wrong About Addiction Recovery | The Saving Dose Ep. 20
    2026/11/17

    Pete Rubinas is the Chief Executive Officer of SMART Recovery USA, a national nonprofit offering a secular, skills-based approach to overcoming addictive behaviors. He came to this work first as a participant, after watching someone close to him change and later building a more balanced life of his own.
    Before leading the organization, he facilitated meetings, helped launch family and friends groups across North Carolina’s research triangle, and served as the state’s regional coordinator. His earlier career included a decade in internal controls and risk management at PricewaterhouseCoopers and another decade leading a nonprofit Montessori school. A University of Notre Dame graduate, Pete lives just outside Chapel Hill and still volunteers as a local facilitator.

    In this episode, Pete challenges some of the most accepted assumptions in addiction recovery: that there is one right path, that the medical model explains everything, that family history determines outcome, and that the people trying hardest to help aren’t sometimes making things worse. He introduces SMART’s four-point program, explains how the CRAFT approach is changing what family support looks like, and shares his own story of spending nearly forty years believing a difficult inheritance was his destiny before discovering otherwise.

    Timestamps

    00:00 Welcome and introduction
    02:26 Pete’s background: PricewaterhouseCoopers, Montessori, and finding SMART
    05:15 Why SMART Recovery exists and what makes it different
    07:50 The family and friends program and how CRAFT works
    10:34 Stigma inside the recovery community
    13:22 Vietnam veterans, heroin, and the power of community
    17:20 What families get wrong when trying to help
    21:45 Whole-person care and the limits of a single diagnosis
    25:34 Why policy made for populations fails individuals
    28:16 Replacing one passion with another: John’s soccer player patient
    30:13 AI in addiction recovery and what it gets right or wrong
    32:49 The black hole at the front door: 75% of patients take medications incorrectly
    37:00 Pete’s personal journey and growing up in a home affected by alcohol
    41:23 Why Pete doesn’t use the words “alcoholic” or “disease”
    47:20 Language, stigma, and why words determine whether people ask for help
    49:38 Why medication and psychosocial support need each other
    50:23 How to find SMART Recovery and what to expect at your first meeting

    About the Hosts

    William Pedranti is co-founder and COO of iPill Adherence Tech Services and co-host of The Saving Dose. A Georgetown Law graduate who spent 15 years building biotech companies rather than practicing law, William has taken a company from founding through FDA approval, commercial launch, and exit. He lectures at USC on what venture capital actually evaluates in biomedical investments and simultaneously serves as CEO of Visgenx.

    Dr. John Hsu MD is co-founder and CEO of iPill Adherence Tech Services and co-host of The Saving Dose. An anesthesiologist with 25 years of pain management experience, John is a serial FDA regulatory builder who has taken multiple products through approval and commercial launch.

    About the Guest

    Pete Rubinas is Chief Executive Officer of SMART Recovery USA, a mutual help organization offering a secular, skills-based alternative to 12-step programs for people working through addictive behaviors and their families. He began his recovery journey in January 2017 and continues to facilitate local meetings in Chapel Hill, North Carolina. Find SMART Recovery at smartrecovery.org or through the SMART Recovery app on iOS and Android.

    Resources

    Learn more about The Saving Dose at thesavingdose.com.

    If you or someone you know is struggling with addiction, free, confidential help is available 24/7 through the SAMHSA National Helpline: 1-800-662-4357.

    #addiction #recovery #SMARTRecovery #opioidcrisis #mentalhealthawareness #familysupport #thesavingdose #opioiduserecovery #substanceusedisorder #addictionrecovery

    続きを読む 一部表示
    55 分
  • Addiction, Stigma, and the Treatment Gap| The Saving Dose Ep. 17 Ft. Dr. Michael Genovese
    2026/10/27

    In this episode of The Saving Dose, Dr. John Hsu and William Pedranti are joined by Dr. Michael Genovese, a board-certified psychiatrist and attorney whose rare dual training gives him an unusually clear view of both the clinical and legal dimensions of behavioral health. As Chief Medical Officer of Behavioral Health at Access Telecare, he leads the nation’s largest acute specialty telemedicine platform, helping hospitals deliver psychiatric and addiction care where it’s needed most. He previously served as Chief Medical Officer at Acadia Healthcare, the largest standalone behavioral health provider in the United States, and brings more than two decades of hands-on experience as an addiction specialist. He is a longtime advocate for first responders and attorneys in recovery, and recently joined the boards of the National Eating Disorders Association and Banyan Treatment Centers.

    This conversation covers the clinical and legal realities that shape how addiction is treated in America and why nearly two-thirds of people who need treatment for substance use disorders never receive it. Dr. Genovese and the hosts examine how stigma distorts clinical decision-making, what the medical community still gets wrong about opioid use disorder, and why treating the whole patient, not just the disorder, is the only approach that holds.

    00:00 Introduction
    02:01 Dr. Genovese’s path from law to medicine
    05:46 Why psychiatry captured a doctor trained for cardiology
    08:23 From one patient at a time to a facility of people
    10:16 How telemedicine reaches patients no specialist could otherwise see
    12:01 How a law degree changes the way a doctor practices medicine
    16:14 What doctors still get wrong about addiction and stigma
    18:58 When stigma becomes malpractice: cases where bias caused harm
    22:41 The CDC’s 90 MME guideline and what it actually did to patients
    23:48 Telehealth for opioid use disorder: better or worse?
    26:10 Only 15 to 20 percent of OUD patients get treatment, and we know how to change that
    28:20 First responders, the FBI National Academy, and the stigma that runs deepest
    31:16 Veterans, VR treatment, and 44 deaths a day
    37:31 Is buprenorphine trading one addiction for another?
    38:41 Why psychosocial support cannot be separated from medication
    40:11 Multidisciplinary pain treatment and why it collapsed
    41:02 What it will actually take to solve the opioid crisis
    43:37 Ignorance is not an excuse: 5,000 addictionologists for 48 million people
    46:12 One legal or regulatory change to unlock mental health and addiction care

    About the Hosts

    John Hsu, MD is the Founder and CEO of iPill and a practicing anesthesiologist with 25 years in pain management and addiction medicine. He has taken multiple products through FDA approval and commercial launch.

    William Pedranti is the COO of iPill, a Georgetown Law graduate, and co-founder of PENG Life Science Ventures. He has taken a biotech company from founding through FDA approval, commercial launch, and exit.

    About the Guest

    Dr. Michael Genovese is a board-certified psychiatrist and attorney serving as Chief Medical Officer of Behavioral Health at Access Telecare, the nation’s largest acute specialty telemedicine platform. He previously served as Chief Medical Officer at Acadia Healthcare, the largest standalone behavioral health provider in the United States. With more than two decades of experience as an addiction specialist, he is a longtime advocate for first responders and attorneys in recovery. He recently joined the boards of the National Eating Disorders Association and Banyan Treatment Centers.

    Website: thesavingdose.com

    This podcast is for educational purposes only and does not constitute medical advice. Consult a qualified healthcare professional before making any treatment decisions.

    If you or someone you know is struggling with substance use disorder, contact SAMHSA’s National Helpline at 1-800-662-4357. Free, confidential, 24/7.

    #AddictionMedicine #BehavioralHealth #TheSavingDose #OpioidCrisis #SubstanceUseDisorder #Psychiatry #Telemedicine #AddictionRecovery #Stigma #OpioidUseDIsorder #MOUD #MentalHealth #FirstResponders #HealthcarePodcast #StigmaKills #BrainHealth #PublicHealth #RecoveryPodcast #AccessTelecare #PsychiatryPodcast

    続きを読む 一部表示
    54 分
  • The Politics of Addiction | The Saving Dose Ep. 16 ft. Andrew Kessler
    2026/10/20

    In the sixteenth episode of The Saving Dose, Dr. John Hsu and William Pedranti are joined by Andrew D. Kessler, JD, founder and principal of Slingshot Solutions LLC, a Washington, DC behavioral health policy consulting firm with more than two decades of experience navigating Congress, the White House Office of National Drug Control Policy, SAMHSA, and NIDA on behalf of treatment providers, advocacy organizations, and professional associations.

    Andrew has written legislation and report language passed by both the House and Senate, presented before the Scientific Management Review Board, the College on Problems of Drug Dependence, and the National Conference on Addictive Disorders, and is a frequent contributor to Politico, The Hill, and Alcohol and Drug Abuse Weekly. He is one of the few people in this space who understands both what advocates need and why Capitol Hill consistently fails to deliver it, and he says so plainly.

    00:00 Introduction
    02:34 Andrew’s path from Capitol Hill intern to DC policy specialist
    07:53 Why Slingshot Solutions has nothing to do with David and Goliath
    10:02 The fourth decade of the opioid epidemic and the gap between suffering and policy
    11:06 Why stigma is still the number one obstacle on Capitol Hill
    13:00 Addiction as a brain disease: what society still does not understand
    14:25 How Hollywood shapes what policymakers think treatment looks like
    17:44 The $4 trillion problem and why 85% of people with OUD never get treatment
    24:20 The three-legged stool: prevention, treatment, and recovery
    26:07 Reducing overdose deaths by more than 50% is possible, so why aren’t we
    29:38 The workforce crisis: retention, not recruitment, is the problem
    31:53 Why Medicaid reimbursement for SUD has never recovered from the 1960s
    35:40 The $57 billion opioid litigation settlement and what actually happened to it
    43:12 If the president gave you one year and full backing: Andrew’s three moves
    51:47 Homelessness, addiction, and what the current administration is actually saying
    54:38 Robert F. Kennedy Jr., 14 years of heroin addiction, and zero days homeless
    57:56 A vision without funding is a hallucination: how Andrew holds the White House accountable
    1:00:46 What Slingshot Solutions does and how to reach Andrew

    About the Hosts

    John Hsu, MD is the Founder and CEO of iPill and a practicing anesthesiologist with 25 years in pain management and addiction medicine. He has taken multiple products through FDA approval and commercial launch.

    William Pedranti is the COO of iPill, a Georgetown Law graduate, and co-founder of PENG Life Science Ventures. He has taken a biotech company from founding through FDA approval, commercial launch, and exit.

    About the Guest

    Andrew D. Kessler, JD is the founder and principal of Slingshot Solutions LLC, a Washington, DC consulting firm specializing in behavioral health policy. With more than 20 years of experience in substance use disorder policy, he has written legislation and report language passed by both the House and Senate, collaborated with congressional offices, the White House ONDCP, NIDA, and SAMHSA, and represented organizations including the International Certification and Reciprocity Consortium, the California Consortium of Addiction Programs and Professionals, and Faces and Voices of Recovery. He is a frequent contributor to Politico, The Hill, and Alcohol and Drug Abuse Weekly, and speaks nationally on substance use policy and advocacy. He speaks in a personal capacity.

    Website: thesavingdose.com

    This podcast is for educational purposes only and does not constitute medical advice. Consult a qualified healthcare professional before making any treatment decisions.

    If you or someone you know is struggling with substance use disorder, contact SAMHSA’s National Helpline at 1-800-662-4357. Free, confidential, 24/7.

    #OpioidPolicy #AddictionRecovery #BehavioralHealth #TheSavingDose #DrugPolicy #SubstanceUseDisorder #ONDCP #SAMHSA #NIDA #OpioidCrisis #HarmReduction #MOUD #MedicaidPolicy #AddictionMedicine #PublicHealth #RecoveryPodcast #StigmaKills #HealthcarePodcast #SlinghotSolutions #OpioidSettlement

    続きを読む 一部表示
    1 時間 6 分
  • Inside Hospital Drug Diversion | The Saving Dose Ep. 15 ft. Terri Vidals
    2026/10/13

    Terri Vidals has spent more than 35 years in pharmacy, with the last 15 focused on a problem most healthcare institutions prefer not to discuss: drug diversion by their own staff. She founded Rxpert Solutions to help hospitals assess where their diversion vulnerabilities actually are and build programs that close them. She hosts the Drug Diversion Insights Podcast. She knows what the automated dispensing machines catch, what they miss, and what happens to patients when a clinician replaces fentanyl with saline.

    In this conversation with Dr. John Hsu and William Pedranti, Terri walks through the mechanics of diversion at the point of care, the accountability frameworks that protect patients without destroying careers, and why the home monitoring environment remains a blind spot no current system addresses.

    Chapters:
    [[00:00]] Introduction and Terri’s background
    [[10:46]] What happens when the vial has been tampered
    [[15:41]] The home monitoring black hole: no visibility after the cabinet
    [[19:00]] Diversion rates among healthcare professionals: 10 to 20 percent
    [[25:00]] Accountability vs. compassion: remove from bedside, investigate fully
    [[32:00]] The false accusation: when reporting gets used as a weapon
    [[38:00]] MOUD access and the 75% who cannot get medication
    [[43:44]] What Terri would mandate at every hospital in the country
    [[49:11]] Closing

    Connect with Terri Vidals:
    LinkedIn: https://www.linkedin.com/in/terri-vidals

    About The Saving Dose:
    The Saving Dose is a podcast about what it actually takes to close the gap between the medication adherence crisis and the patients who need care. Hosted by Dr. John Hsu, an anesthesiologist and pain management physician with 25 years of experience, and William Pedranti, a healthcare attorney and biotech operator who has taken companies from founding through FDA approval and commercial exit.

    New episodes every Tuesday. Subscribe on Spotify, Apple Podcasts, and YouTube.

    続きを読む 一部表示
    51 分
  • What the UK Got Right About Addiction | The Saving Dose Ep. 14 Ft. Mark Gilman
    2026/10/06
    Mark Gilman has worked inside the opioid crisis from every angle for more than 40 years: as a researcher, a policy architect, a commissioner, a clinician, and a patient. He designed the Through the Gate program for NHS England, which put medication-assisted treatment inside prisons and continued it through release. He helped build the harm reduction infrastructure that prevented the UK's HIV response from becoming a second catastrophe. He started self-medicating at 12 after his father's death, spent years navigating addiction before going to university, and built a career dedicated to fixing the systems that had failed him.In this conversation with Dr. John Hsu, Mark makes the case that the United States already has the evidence it needs. The question is whether it will use it.What they cover:The UK's 1981 brown powder heroin epidemic and why unemployment, displacement, and loss of identity drove addiction rates more than drug availabilityWhy policing a drug market is like standing on a balloon: push it down in one place, it pops up somewhere else, because the markets are demand-ledHow harm reduction began as a peer-led self-help movement with no government support and became national policy when Margaret Thatcher's government decided HIV was a greater threat than drug misuseThe abstinence-without-medication success rate: 2 to 7 percentWhy people are 129 times more likely to die in the two weeks after prison release in the US, and 25 times more likely in the UK, and what the Through the Gate program does to close that windowThe Retox concept: stabilizing people on MOUD inside prison so medication continues seamlessly from the prison gate into the communityHeroin-assisted therapy and the Basel model: patients in Switzerland can choose between injectable diamorphine, a nasal spray, or a 200mg tablet, and early observations show a shift toward the tablet because what people actually want is jobs, homes, and friendsThe subset of patients, less than 10%, with severe trauma histories for whom buprenorphine doesn't work because greater cognitive clarity brings the trauma backStigma inside the recovery community itself, including 12-step fundamentalists who tell people taking ADHD medication that they've relapsed, and why Mark argues that internal cultural stigma causes more damage than state stigmaVietnam veterans: 25% of soldiers became heroin addicts during the war; 85 to 90% simply stopped when they came home to jobs, homes, and a sense of purposeThe biopsychosocial model and the case for adding a fourth dimension: spiritual, meaning a sense of meaning and purpose, not religion specificallyChapters:[00:00] Introduction and Mark's background[01:01] Self-medicating at 12 after his father's death[01:42] University, two degrees, and entering the field[02:09] The six elements of OUD: research, policy, practice, commissioning, providers, and patient[03:22] The UK's 1981 brown powder heroin epidemic[05:26] Pain, unemployment, and displacement as the drivers of addiction[06:48] Why policing drug markets is like standing on a balloon[08:52] Harm reduction as a peer-led self-help movement[10:07] How Thatcher's Conservative government pragmatically backed harm reduction[13:36] Recovery requires more than medication: jobs, friends, and houses[15:30] The abstinence-without-medication success rate: 2 to 7%[17:59] The history of diamorphine prescribing in the UK since 1926[19:59] Buprenorphine and the subset it doesn't serve[21:11] Heroin-assisted therapy and the Basel model[23:05] Stigma from OUD's history as a moral or criminal failing[24:31] NIMBY: why clinics end up on the wrong side of town[25:02] Stigma inside recovery communities: ADHD medication and 12-step fundamentalism[27:01] Four decades of the US opioid epidemic and the case for looking outward[28:43] Prison, recidivism, and the 75% three-month return rate[31:22] The two-week death window after prison release: 25x in the UK, 129x in the US[32:32] Through the Gate: seamless handover at the prison gate[33:04] The two pathways in prison: abstinence-based or MOUD stabilization[36:01] Why short sentences create a revolving door of detoxification and death[39:08] The growing crisis of meaning and ketamine among young people[40:00] Vietnam veterans: most stopped using when they came home to a life[42:27] Dignity, the diversion concern, and the Basel diamorphine tablet options[46:21] The final question: what would you change from your early career?[47:27] The biopsychosocial model and the case for a fourth dimension: spiritual[48:15] John's patient who found meaning in a peer support group at a church[49:51] ClosingConnect with Mark Gilman:LinkedIn: https://www.linkedin.com/in/mark-gilman-0597012b/About The Saving Dose:The Saving Dose is a podcast about what it actually takes to close the gap between the medication adherence crisis and the patients who need care. Hosted by Dr. John Hsu, an anesthesiologist and pain management physician with 25 years of experience, ...
    続きを読む 一部表示
    52 分
  • How Stigma Keeps People from Getting Help | The Saving Dose Ep. 13 Ft. Melissa Shackleford
    2026/09/29

    Melissa Shackleford has been in addiction recovery for 37 years. She got sober as a college freshman, went on to spend a decade as SVP of Marketing at Hazelden Betty Ford, and built a career at the intersection of healthcare marketing and behavioral health. She is a TEDx speaker, Amazon #1 bestselling author of Harnessing Purpose, and founder of Shackleford Strategies.

    In this conversation with Dr. John Hsu and William Pedranti, Melissa breaks down why stigma is not just a cultural problem but a clinical one. She's seen it from both sides: as a person in long-term recovery and as the marketing executive who had to fight to remove stigmatizing language from Hazelden's own outreach materials.

    What they cover:

    • Why the language we use determines whether someone seeks help or disappears
    • The person-first language shift and why it matters beyond addiction
    • The Gallup and Shatterproof stigma studies and what the data reveals about how little has changed
    • Why doctors call OUD patients "difficult" when no one says that about diabetics who won't follow their diet
    • The buprenorphine shame problem inside 12-step recovery communities
    • Medicaid's 8-to-9-month wait for OUD treatment and who loses their life in that window
    • Why pharmacies refusing to stock MOUD medications is a form of stigma with real body counts
    • What Hazelden Betty Ford got right about messaging: lead with hope, not shock
    • John's La Joya house: giving six bedrooms to a sober living facility because no neighborhood wants treatment next door
    • The one change Melissa asks every doctor, pharmacist, and family member to make

    Chapters:
    00:00 Introduction and Melissa's background
    02:30 Getting sober at 18: what that looked like
    05:00 Why person-first language is not political, it's medical
    08:00 The parking lot pill count story (and what it says about how we treat patients)
    10:00 Stigma inside the recovery community: buprenorphine and 12-step
    15:30 MAT stigma and the barriers it creates
    17:00 Medicaid pays 80% of OUD treatment, then makes patients wait 9 months
    18:40 John's sober living house and the "not in my backyard" problem
    20:00 Why OUD patients are labeled "difficult" when no chronic condition patient is
    22:00 Long-term MAT: the three schools of thought
    24:00 How the drug supply changed: from prescription opioids to fentanyl-laced everything
    25:00 Treating the body and the mind: why medication alone is not recovery
    26:00 MAT and the work requirement trap: losing Medicaid means losing medication
    28:00 Pharmacies that refuse to stock MOUD medications
    28:44 These medications reduce overdose-related death by more than 50%
    31:00 OUD providers keeping secret lists of pharmacies that will fill prescriptions
    32:00 Trust as the currency of healthcare
    33:00 Hazelden's messaging strategy: pull out stigmatizing imagery entirely
    35:00 People call treatment centers on the worst day of their life
    37:00 The one thing to change: use person-first language
    40:00 Addiction is not a choice, it's not a moral failing
    41:00 Cancer has pink ribbons. Why does addiction still carry shame?
    43:00 About Shackleford Strategies and how to connect with Melissa
    44:10 Closing

    Connect with Melissa Shackleford:
    LinkedIn: linkedin.com/in/melissashackleford
    Website: https://melissaforsshackelford.com/

    About The Saving Dose:
    The Saving Dose is a podcast about what it actually takes to close the gap between the medication adherence crisis and the patients who need care. Hosted by Dr. John Hsu, an anesthesiologist and pain management physician with 25 years of experience, and William Pedranti, a healthcare attorney and biotech operator who has taken companies from founding through FDA approval and commercial exit.

    New episodes every Tuesday. Subscribe on Spotify, Apple Podcasts, and YouTube.

    The Saving Dose is produced by iPill Adherence Tech Services. All content is for educational and informational purposes only and does not constitute medical advice.

    続きを読む 一部表示
    45 分
  • The Drug That Can Make Pain Worse | The Saving Dose Ep. 12 Ft. Prof. Patrice Forget
    2026/09/22

    In the twelfth episode of The Saving Dose, Dr. John Hsu and William Pedranti are joined by Professor Patrice Forget, a Belgian anesthesiologist and pain researcher now based in the United Kingdom. With more than 250 peer-reviewed publications, Professor Forget chairs the PANDOS research group (Pain and Opioids After Surgery) at the European Society of Anesthesiology and Intensive Care, serves as a board member and honorary treasurer of the European Pain Federation, and is deputy editor-in-chief of the European Journal of Anesthesiology. His work bridges clinical practice, large-scale epidemiology, and policy at the intersection of post-operative pain management, opioid use, and long-term outcomes.

    This episode goes further into the clinical science of opioids than any conversation The Saving Dose has had. Professor Forget challenges assumptions that have shaped prescribing practice for decades, including the idea that more opioids during surgery means less pain after it.

    00:00 Introduction
    02:06 Professor Forget's background and path from Brussels to the UK
    04:00 How fentanyl was developed in Belgium and what it was originally designed to do
    07:15 Opioid-induced hyperalgesia: what it is and why it matters
    10:00 The Liverpool technique and the history of balanced anesthesia
    12:00 Why large doses of opioids can increase pain sensitivity rather than reduce it
    16:00 The preemptive analgesia theory and why the data rejected it
    20:00 How not all patients respond to opioids the same way
    24:00 What European post-surgical data shows about long-term opioid outcomes
    28:00 The gap between what research shows and what policy assumes
    32:00 Opioid stewardship and responsible prescribing in a post-crisis environment
    38:00 John on cardiac anesthesia and the clinical reality of high-dose opioid use
    44:00 What the field still does not know and where research is heading
    50:00 What better perioperative pain management could mean for addiction prevention

    About the Hosts

    John Hsu, MD is the Founder and CEO of iPill and a practicing anesthesiologist with 25 years in pain management and addiction medicine. He has taken multiple products through FDA approval and commercial launch.

    William Pedranti is the COO of iPill, a Georgetown Law graduate, and co-founder of PENG Life Science Ventures. He has taken a biotech company from founding through FDA approval, commercial launch, and exit.


    About the Guest

    Professor Patrice Forget is a Belgian anesthesiologist and pain researcher based in the United Kingdom. He chairs the PANDOS (Pain and Opioids After Surgery) research group at the European Society of Anesthesiology and Intensive Care and serves as a board member and honorary treasurer of the European Pain Federation. He is deputy editor-in-chief of the European Journal of Anesthesiology and a past president of the Belgian Pain Society. He has authored more than 250 peer-reviewed publications on perioperative epidemiology, clinical pharmacology, and opioid stewardship.

    Website: thesavingdose.com

    This podcast is for educational purposes only and does not constitute medical advice. Consult a qualified healthcare professional before making any treatment decisions.


    If you or someone you know is struggling with substance use disorder, contact SAMHSA's National Helpline at 1-800-662-4357. Free, confidential, 24/7.

    #ChronicPain #OpioidCrisis #PainManagement #AddictionRecovery #TheSavingDose #OpioidInducedHyperalgesia #Anesthesiology #PeroperativeCare #OpioidStewardship #SurgicalPain #PainMedicine #Buprenorphine #SubstanceUseDisorder #HealthcarePodcast #EuropeanPainFederation #PANDOS #OpioidPolicy #AddictionMedicine #ChronicPainManagement #PublicHealth

    続きを読む 一部表示
    44 分